Validation of Enzymatic Activity of SynGAP1 as a Therapeutic Target for Autism Spectrum Disorders, toward High Throughput Compound Screening

Project Details

StatusActive
Effective start/end date1/04/2231/03/23

Funding

  • Non-EU industry, commerce and public corporations: £110,362.00